Department of Urology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan.
Department of Urology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan; Department of Hereditary Kidney Disease Research, Kyorin University School of Medicine, Tokyo, Japan.
J Stroke Cerebrovasc Dis. 2021 Sep;30(9):105943. doi: 10.1016/j.jstrokecerebrovasdis.2021.105943. Epub 2021 Jun 25.
the prevalence of intracranial aneurysms and arachnoid cysts is higher in patients with autosomal dominant polycystic kidney disease (ADPKD) than in the general population. A genotype correlation was reported for intracranial aneurysms, but it is unclear for arachnoid cysts. Therefore, the genotype correlation with intracranial aneurysms and arachnoid cysts was investigated in ADPKD.
intracranial aneurysms and arachnoid cysts were screened by magnetic resonance imaging (MRI), and PKD genotypes were examined using next-generation sequencing for 169 patients with ADPKD.
PKD1-, PKD2- and no-mutation were identified in 137, 24 and 8 patients, respectively. Intracranial aneurysms and arachnoid cysts were found in 34 and 25 patients, respectively, with no significant difference in frequency. Genotype, sex, estimated glomerular filtration rate and age at ADPKD diagnosis significantly affected the age at brain MRI. The proportional hazard risk analyzed using the age at brain MRI adjusted by these four variables was 5.0-times higher in the PKD1 group than in the PKD2 group for arachnoid cysts (P = 0.0357), but it was not different for intracranial aneurysms (P = 0.1605). Arachnoid cysts were diagnosed earlier in the PKD1 group than in the PKD2 group (54.8 vs 67.7 years, P = 0.0231), but no difference was found for intracranial aneurysms (P = 0.4738) by Kaplan-Meier analysis.
this study demonstrated the correlation between arachnoid cysts and PKD1 mutation. The reported association of arachnoid cysts with advanced renal disease may be due to the common correlation of these factors with PKD1 mutation.
常染色体显性多囊肾病(ADPKD)患者颅内动脉瘤和蛛网膜囊肿的患病率高于普通人群。已有研究报道颅内动脉瘤与基因型相关,但蛛网膜囊肿的基因型相关性尚不清楚。因此,本研究旨在探讨 ADPKD 患者颅内动脉瘤和蛛网膜囊肿与基因型的相关性。
通过磁共振成像(MRI)筛查颅内动脉瘤和蛛网膜囊肿,并对 169 例 ADPKD 患者进行下一代测序以检测 PKD 基因型。
137 例患者存在 PKD1 突变,24 例患者存在 PKD2 突变,8 例患者未检测到突变。34 例患者发现颅内动脉瘤,25 例患者发现蛛网膜囊肿,两者的发生率无显著差异。基因型、性别、估算肾小球滤过率和 ADPKD 诊断时的年龄显著影响脑 MRI 的年龄。通过调整上述四个变量后的脑 MRI 年龄进行比例风险分析,蛛网膜囊肿在 PKD1 组的风险比为 PKD2 组的 5.0 倍(P=0.0357),但颅内动脉瘤无差异(P=0.1605)。Kaplan-Meier 分析显示,蛛网膜囊肿在 PKD1 组的诊断年龄早于 PKD2 组(54.8 岁比 67.7 岁,P=0.0231),但颅内动脉瘤无差异(P=0.4738)。
本研究表明蛛网膜囊肿与 PKD1 突变相关。先前报道蛛网膜囊肿与晚期肾脏疾病相关可能是由于这些因素与 PKD1 突变的共同相关性。